TY  - GEN
AU  - Baniandres-Rodriguez, Ofelia
AU  - Vilar-Alejo, Jaime
AU  - Rivera, Raquel
AU  - Carrascosa, Jose Manuel
AU  - Dauden, Esteban
AU  - Herrera-Acosta, Enrique
AU  - Sahuquillo-Torralba, Antonio
AU  - Gomez-Garcia, Fran J
AU  - Nieto-Benito, Lula Maria
AU  - de la Cueva, Pablo
AU  - Lopez-Estebaranz, Jose Luis
AU  - Belinchon, Isabel
AU  - Ferran-Farres, Marta
AU  - Alsina, Merce
AU  - Rodriguez-Fernandez-Freire, Lourdes 
AU  - Carretero, Gregorio
AU  - Garcia-Donoso, Carmen
AU  - Ballesca, Ferran
AU  - Llamas-Velasco, Mar
AU  - Herrera-Ceballos, Enrique
AU  - Botella-Estrada, Rafael
AU  - Ruiz-Genao, Diana Patricia
AU  - Riera-Monroig, Josep
AU  - Descalzo-Gallego, Miguel Angel
AU  - Garcia-Doval, Ignacio
PY  - 2020
DO  - 10.1016/j.jaad.2020.10.046
UR  - http://hdl.handle.net/10668/16501
T2  - Journal of the American Academy of Dermatology
AB  - To the Editor: The use of systemic treatments in psoriatic patients during the pandemic has been the subject of extensive debate. In March 2020, weperformed a specific study within the cohort of Biobadaderm Registry, a previously described national,...
LA  - en
PB  - Elsevier
KW  - Psoriasis
KW  - Registries
KW  - Severity of Illness Index
KW  - Spain
KW  - Adult
KW  - Aged
KW  - COVID-19
KW  - Cohort Studies
KW  - Female
KW  - Humans
KW  - Incidence
KW  - Male
KW  - Middle Aged
TI  - Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
TY  - letter to the editor
VL  - 84
ER  -